Vaughan Nelson Investment Management, L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Vaughan Nelson Investment Management, L.P.

  • $11.2 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 13, 2022
SELL
$543.48 - $670.97 $135,870 - $167,742
-250 Closed
0 $0
Q3 2021

Oct 27, 2021
BUY
$574.03 - $680.96 $143,507 - $170,240
250 New
250 $151,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Vaughan Nelson Investment Management, L.P. Portfolio

Follow Vaughan Nelson Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email